Targeting Ebola virus -- and more As Watanabe explains, targeting the nucleocapsid spells game over for the virus. "If you don't have a nucleocapsid, nothing can happen.

In a new study, the researchers used cryo-electron tomography to examine Ebola virus’s molecular structure to uncover targets for broadly effective antivirals. This work is published in Cell ...

In a new Cell study, scientists in LJI's Center for Vaccine Innovation share the first detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may ...

A large outbreak of Marburg virus in Rwanda is drawing international concern about the possibility of spread beyond the ...

Rwanda says eight people have died so far from the Ebola-like and highly contagious Marburg virus, just days after the ...

Rwanda has reported eight deaths attributed to the highly contagious Marburg virus, an Ebola-like disease, just days after declaring an outbreak of the deadly hemorrhagic fever, which currently ...

“The world really has to just be ready for that.” Marburg virus is a “cousin” to Ebola virus, which killed more than 11,000 people during an outbreak in West Africa between 2014 and ...

The virus was first identified in 1967 during outbreaks in Germany and Serbia, traced to African monkeys that had been imported for research. (Photo: Getty Images) Eight people have died because of ...

(NEXSTAR) – Health officials in Rwanda are dealing with the country’s first outbreak of the Marburg virus, an Ebola-like disease which, if left untreated, has a fatality rate of up to 88%.

There are no confirmed cases of Marburg virus disease - a rare but deadly hemorrhagic disease similar to Ebola - outside Rwanda, and officials have said that the current risk to the US is low.